Ugur Akcan

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Methyl-beta-cyclodextrin and myriocin alleviate blood-brain barrier impairment in septic rats.

Methyl-beta-cyclodextrin and myriocin alleviate blood-brain barrier impairment in septic rats.

Journal: Histochemistry and cell biology

Published: August 30, 2025

Targeting the blood-brain barrier disruption in hypertension by ALK5/TGF-Β type I receptor inhibitor SB-431542 and dynamin inhibitor dynasore.

Targeting the blood-brain barrier disruption in hypertension by ALK5/TGF-Β type I receptor inhibitor SB-431542 and dynamin inhibitor dynasore.

Journal: Brain research

Published: June 23, 2022

Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo.

Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 05, 2022

Blood-brain barrier targeted delivery of lacosamide-conjugated gold nanoparticles: Improving outcomes in absence seizures.

Blood-brain barrier targeted delivery of lacosamide-conjugated gold nanoparticles: Improving outcomes in absence seizures.

Journal: Epilepsy research

Published: June 27, 2021

Tissue distribution and cellular localization of gold nanocarriers with bound oligonucleotides.

Tissue distribution and cellular localization of gold nanocarriers with bound oligonucleotides.

Journal: Nanomedicine (London, England)

Published: April 14, 2021

Targeted delivery of lacosamide-conjugated gold nanoparticles into the brain in temporal lobe epilepsy in rats.

Targeted delivery of lacosamide-conjugated gold nanoparticles into the brain in temporal lobe epilepsy in rats.

Journal: Life sciences

Published: January 20, 2020

Inflammation and Neurodegeneration in Patients with Early-Stageand Chronic Bipolar Disorder

Inflammation and Neurodegeneration in Patients with Early-Stageand Chronic Bipolar Disorder

Journal: Turk psikiyatri dergisi = Turkish journal of psychiatry

Published: September 06, 2019

Effects of methyl-beta-cyclodextrin on blood-brain barrier permeability in angiotensin II-induced hypertensive rats.

Effects of methyl-beta-cyclodextrin on blood-brain barrier permeability in angiotensin II-induced hypertensive rats.

Journal: Brain research

Published: November 01, 2018

Reduced Peripheral Blood Mononuclear Cell ROCK1 and ROCK2 Levels in Obstructive Sleep Apnea Syndrome.

Reduced Peripheral Blood Mononuclear Cell ROCK1 and ROCK2 Levels in Obstructive Sleep Apnea Syndrome.

Journal: In vivo (Athens, Greece)

Published: December 11, 2017

Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels.

Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels.

Journal: Acta neuropsychiatrica

Published: April 13, 2017

Viability of SH-SY5Y cells is associated with purinergic P2 receptor expression alterations.

Viability of SH-SY5Y cells is associated with purinergic P2 receptor expression alterations.

Journal: Acta biologica Hungarica

Published: March 22, 2017

Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis.

Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis.

Journal: Intensive care medicine experimental

Published: June 17, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026